Delivery Order SPE2DB20D3505-SPE2DB23FU0L2
Award Date 4/28/23
Potential Completion Date 5/1/23
Potential Value $2.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Jolessa 0.15 mg-0.03 mg tablets, a pharmaceutical product, with a ceiling value of $1,178.45 and a performance period ending on June 26, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Jolessa 0.15 mg-0.03 mg tablets. The $1,109.49 firm fixed-price contract has an ultimate completion date of October 8, 2024. Amerisourcebergen is the prime contractor, and there is no set-aside designation indicated. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, the prime contractor, for the delivery of Jolessa 0.15 mg-0.03 mg tablets. The contract is a firm fixed price delivery order with a ceiling value of $1,019.54 and a performance period through March 25, 2024. AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation, is providing these pharmaceutical products to support military...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,104.25 firm-fixed-price contract is for the supply of Jolessa 0.15 mg-0.03 mg tablets. The contract has an ultimate completion date of April 17, 2024 and is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product. The contract has a firm fixed price of $1,432.08 and a period of performance ending on May 28, 2025. The contract is not set-aside and is open to full and open competition. AmerisourceBergen Drug Corp holds...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,727.16, is for the delivery of the prescription medication JOLESSA 0.15 MG-0.03 MG TABLET 91S. The contract has an ultimate completion date of September 12, 2022 and is a firm fixed-price contract. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a...
- This federal contract award, valued at $1,136.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a medical product, and has an ultimate completion date of December 10, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical products on September 24, 2025, with an ultimate completion date of September 25, 2025. The contract covers the supply of Jolessa 0.15 mg-0.03 mg tablets (91-count), a hormonal contraceptive medication, with a ceiling value of $1,545.28. This delivery order is issued under a firm fixed-price arrangement with no set-aside designation, indicating competitive award to the qualified vendor. The...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the delivery of JOLESSA 0.15 MG-0.03 MG TABLET 91S. The contract has a ceiling value of $1,213.53 and an ultimate completion date of May 21, 2024. It is a firm fixed-price delivery order contract type. The award is not associated with a set-aside program. AmerisourceBergen Drug Corp. is a major pharmaceutical distributor and healthcare solutions provider that supplies medical products...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product, with a ceiling value of $1,035.84 and a performance period ending on May 28, 2025. The contract is a Firm Fixed Price (FFP) delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug...